Tordsson et al., 1997 - Google Patents
Efficient selection of scFv antibody phage by adsorption to in situ expressed antigens in tissue sectionsTordsson et al., 1997
- Document ID
- 10759378199697931489
- Author
- Tordsson J
- Abrahmsén L
- Kalland T
- Ljung C
- Ingvar C
- Brodin T
- Publication year
- Publication venue
- Journal of immunological methods
External Links
Snippet
The present report describes the development and application of an efficient method for the direct adsorption/selection of antibody phage using antigens expressed in situ in cryostat tissue sections. In a model system, scFv phage directed towards an epitope on the GA733-2 …
- 102000004965 antibodies 0 title abstract description 78
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/005—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tordsson et al. | Efficient selection of scFv antibody phage by adsorption to in situ expressed antigens in tissue sections | |
| Hoogenboom | Overview of antibody phage-display technology and its applications | |
| Goletz et al. | Selection of large diversities of antiidiotypic antibody fragments by phage display | |
| Krebs et al. | High-throughput generation and engineering of recombinant human antibodies | |
| JP2021121190A (en) | HLA-binding epitope encoded by a somatic mutation gene | |
| RU2488593C2 (en) | Human tumour-associated monoclonal antibody | |
| Giovannoni et al. | Isolation of anti-angiogenesis antibodies from a large combinatorial repertoire by colony filter screening | |
| Mutuberria et al. | Model systems to study the parameters determining the success of phage antibody selections on complex antigens | |
| De Bolle et al. | Antigenic properties of peptidic mimics for epitopes of the lipopolysaccharide from Brucella | |
| Mullaney et al. | Protein-protein interactions in hematology and phage display | |
| Imai et al. | Quality enhancement of the non-immune phage scFv library to isolate effective antibodies | |
| RU2402777C2 (en) | Method of screening phage display library | |
| Pini et al. | Hierarchical affinity maturation of a phage library derived antibody for the selective removal of cytomegalovirus from plasma | |
| US6727062B1 (en) | Identification of target structures E.G. in vivo selection method for a phage library | |
| EP0935604B1 (en) | Magnetically activated cell sorting for production of proteins | |
| WO1998016541A9 (en) | Magnetically activated cell sorting for production of proteins | |
| Teixeira et al. | Phage display technology for selection of antibody fragments | |
| US7425623B2 (en) | Antibody with specificity for colon cancer | |
| Szecsi et al. | Identification of patient‐specific peptides for detection of M‐proteins and myeloma cells | |
| Link et al. | Selection of phage-displayed anti-guinea pig C5 or C5a antibodies and their application in xenotransplantation | |
| Mazuet et al. | Breast carcinoma specific antibody selection combining phage display and immunomagnetic cell sorting | |
| Hegmans et al. | A model system for optimising the selection of membrane antigen-specific human antibodies on intact cells using phage antibody display technology | |
| JP2001515921A (en) | Monoclonal antibodies that bind testosterone | |
| RU2307163C2 (en) | RECOMBINANT FRAGMID DNA pHEN-TAB CONTAINING HUMAN SINGLE-STRAND ANTIBODY GENE, CAPABLE OF BINDING OF HUMAN TUMOR NECROSIS FACTOR ALPHA; RECOMBINANT Escherichia coli BACTERIA STRAIN AS PRODUCER OF HUMAN SINGLE-STRAND ANTIBODY AGAINST HUMAN TUMOR NECROSIS FACTOR ALPHA; RECOMBINANT SOLUBLE HUMAN SINGLE-STRAND ANTIBODY AGAINST HUMAN TUMOR NECROSIS FACTOR ALPHA | |
| Hall et al. | A novel tumor-specific human single-chain Fv selected from an active specific immunotherapy phage display library |